Identification of important interactions between subchondral bone ...

3.4 References for CHAPTER 3
1 von der M.K., Gauss V., von der M.H., and Muller P.
Relationship between cell shape and type of collagen
synthesised as chondrocytes lose their cartilage phenotype
in culture. Nature. 1977;267(5611):531-532.
2 Lee D.A., Reisler T., and Bader D.L. Expansion of
chondrocytes for tissue engineering in alginate beads
enhances chondrocytic phenotype compared to
conventional monolayer techniques. Acta Orthop Scand.
2003;74(1):6-15.
3 Takigawa M., Okawa T., Pan H., Aoki C., Takahashi K.,
Zue J., Suzuki F. et al. Insulin-like growth factors I and II
are autocrine factors in stimulating proteoglycan synthesis,
a marker of differentiated chondrocytes, acting through
their respective receptors on a clonal human
chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
Endocrinology. 1997;138(10):4390-4400.
4 Manning W.K. and Bonner W.M., Jr. Isolation and culture
of chondrocytes from human adult articular cartilage.
Arthritis Rheum. 1967;10(3):235-239.
5 Mackay A.M., Beck S.C., Murphy J.M., Barry F.P.,
Chichester C.O., and Pittenger M.F. Chondrogenic
differentiation of cultured human mesenchymal stem cells
from marrow. Tissue Eng. 1998;4(4):415-428.
6 Neutzsky-Wulff A.V., Karsdal M.A., and Henriksen K.
Characterization of the bone phenotype in ClC-7-deficient
mice. Calcif Tissue Int. 2008;83(6):425-437.
7 Schaller S., Henriksen K., Hoegh-Andersen P.,
Sondergaard B.C., Sumer E.U., Tanko L.B., Qvist P. et al.
In vitro, ex vivo, and in vivo methodological approaches
for studying therapeutic targets of osteoporosis and
degenerative joint diseases: how biomarkers can assist?
Assay Drug Dev Technol. 2005;3(5):553-580.
8 Hascall V.C., Morales T.I., Hascall G.K., Handley C.J.,
and McQuillan D.J. Biosynthesis and turnover of
proteoglycans in organ culture of bovine articular cartilage.
J Rheumatol Suppl. 1983;11:45-52.
9 Sondergaard B.C., Wulf H., Henriksen K., Schaller S.,
Oestergaard S., Qvist P., Tanko L.B. et al. Calcitonin
directly attenuates collagen type II degradation by
inhibition of matrix metalloproteinase expression and
activity in articular chondrocytes. Osteoarthritis Cartilage.
2006;14(8):759-768.
CHAPTER 3: Overview of OA models
48
10 Sondergaard B.C., Henriksen K., Wulf H., Oestergaard S.,
Schurigt U., Brauer R., Danielsen I. et al. Relative
contribution of matrix metalloprotease and cysteine
protease activities to cytokine-stimulated articular cartilage
degradation. Osteoarthritis Cartilage. 2006;14(8):738-748.
11 Charni-Ben T.N., Desmarais S., Bay-Jensen A.C., Delaisse
J.M., Percival M.D., and Garnero P. The type II collagen
fragments Helix-II and CTX-II reveal different enzymatic
pathways of human cartilage collagen degradation.
Osteoarthritis Cartilage. 2008;16(10):1183-1191.
12 Dingle J.T., Horsfield P., Fell H.B., and Barratt M.E.
Breakdown of proteoglycan and collagen induced in pig
articular cartilage in organ culture. Ann Rheum Dis.
1975;34(4):303-311.
13 Fell H.B. and Barratt M.E. The role of soft connective
tissue in the breakdown of pig articular cartilage cultivated
in the presence of complement-sufficient antiserum to pig
erythrocytes. I. Histological changes. Int Arch Allergy
Appl Immunol. 1973;44(3):441-468.
14 Roy-Beaudry M., Martel-Pelletier J., Pelletier J.P., M'Barek
K.N., Christgau S., Shipkolye F., and Moldovan F.
Endothelin 1 promotes osteoarthritic cartilage degradation
via matrix metalloprotease 1 and matrix metalloprotease
13 induction. Arthritis Rheum. 2003;48(10):2855-2864.
15 Saklatvala J. Tumour necrosis factor alpha stimulates
resorption and inhibits synthesis of proteoglycan in
cartilage. Nature. 1986;322(6079):547-549.
16 Cawston T.E., Curry V.A., Summers C.A., Clark I.M.,
Riley G.P., Life P.F., Spaull J.R. et al. The role of
oncostatin M in animal and human connective tissue
collagen turnover and its localization within the
rheumatoid joint. Arthritis Rheum. 1998;41(10):1760-
1771.
17 Sondergaard B.C., Schultz N., Madsen S.H., Bay-Jensen
A.C., Kassem M., and Karsdal M.A. MAPKs are essential
upstream signaling pathways in proteolytic cartilage
degradation--divergence in pathways leading to
aggrecanase and MMP-mediated articular cartilage
degradation. Osteoarthritis Cartilage. 2010;18(3):279-288.
18 Madsen S.H., Sondergaard B.C., Bay-Jensen A.C., and
Karsdal M.A. Cartilage formation measured by a novel
PIINP assay suggests that IGF-I does not stimulate but
maintains cartilage formation ex vivo. Scand J Rheumatol.
2009;38(3):222-226.